Clinical Trial Update: Serelaxin To Lower Portal Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial update on serelaxin for lowering portal pressure in liver cirrhosis and portal hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Serelaxin (serelaxin)

Snippet

Sponsor: University of Edinburgh | Conditions: Liver Cirrhosis, Hypertension, Portal | Phase 2 | Status: COMPLETED